Clinical Trial Update: CLEVER Pilot Trial: A Phase II Pilot Trial of HydroxyChLoroquine, EVErolimus or the Combination for Prevention of Recurrent Breast Cancer [Phase 2]

View source ↗

Summary

This entry reports results from the CLEVER Pilot Trial, a Phase II study evaluating hydroxychloroquine, everolimus, or their combination to prevent recurrent br…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Everolimus (everolimus)
• Hydroxychloroquine (hydroxychloroquine)
• Hydroxychloroquine + Everolimus (combination) (hydroxychloroquine + everolimus)

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Breast Cancer Stage IIB | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-03-05